Chiron Real Estate Inc(XRN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 22 at 4:01 PM ET (Korea 9/23 05:01)
Full metrics table
| Index | RUT | P/E | 9.82 | EPS (ttm) | 3.72 | Insider Own | 9.71% | Shs Outstand | 13.2M | Perf Week | 1.11% |
| Market Cap | 0.53B | Forward P/E | - | EPS next Y | -154.22% | Insider Trans | 6.83% | Shs Float | 11.9M | Perf Month | -1.64% |
| Enterprise Value | 1.41B | PEG | - | EPS next Q | -0.41 | Inst Own | 75.03% | Short Float | 7.2% | Perf Quarter | 2.15% |
| Income | 0.05B | P/S | 3.24 | EPS this Y | 428.85% | Inst Trans | 11.71% | Short Ratio | 9.37 | Perf Half Y | 7.98% |
| Sales | 0.16B | P/B | 1.11 | EPS next 5Y | 16.23% | ROA | 4.34% | Short Interest | 0.86M | Perf YTD | 8.3% |
| Book/sh | 33 | P/C | 34.8 | EPS past 3/5Y | - -1.58% | ROE | 9.99% | 52W High | -8.49% ($39.93) | Perf Year | -3.72% |
| Cash/sh | 1.05 | P/FCF | - | Sales past 3/5Y | 5.52% 11.43% | ROIC | 4.43% | 52W Low | 25.78% ($29.05) | Perf 3Y | -15.08% |
| Dividend Est. | $2.33 (6.36%) | EV/EBITDA | 13.24 | EPS Y/Y TTM | 1006.24% | Gross Margin | 41.17% | Volatility(W/M) | 1.92% 2.13% | Perf 5Y | -48.09% |
| Dividend TTM | 2.14 | EV/Sales | 8.64 | Sales Y/Y TTM | 4.16% | Oper. Margin | 28.53% | ATR (14) | 0.83 | Perf 10Y | -24.27% |
| Dividend Ex-Date | 2026/10/20 | Quick Ratio | 0.78 | EPS Q/Q | 8096.66% | Profit Margin | 30.06% | RSI (14) | 50.78 | Recom | 2.2 |
| Dividend Gr. 3/5Y | -7.72% -3.77% | Current Ratio | 0.78 | Sales Q/Q | -0.63% | SMA20 | -0.18% ($36.61) | Beta | 1.14 | Target Price | $41.12 |
| Payout | - | Debt/Eq | 0.99 | Earnings | 2026/8/5 | SMA50 | -0.17% ($36.6) | Rel Volume | 0.87 | Prev Close | $36.22 |
| Employees | 30 | LT Debt/Eq | 0.99 | EPS/Sales Surpr. | 2134.04% -1.55% | SMA200 | 2.66% ($35.59) | Avg Volume(3M) | 0.09M | Price | $36.54 |
| IPO | 2013/6/21 | Option/Short | Yes/Yes | Trades | 1011 | Volume | 79,723 | Change | 0.88% |
Company
XRN is a Real Estate sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 Carelon Real Estate is a net-lease healthcare REIT specializing in medical facilities. It acquires purpose-built healthcare properties—including medical office buildings, rehabilitation hospitals, surgical hospitals, and outpatient treatment facilities—and leases them on a long-term basis to physician groups and regional or national healthcare systems, seeking to generate stable rental income.
Over the past 1 year, roughly in the middle
8% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend October 20
XRN makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +428.9% this year.
Tap to view numbers
The price looks about right
Trading at 9.8 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -15.1% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 6.36% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 75.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
KBWY 0.04%
RDOG 0.02%
BLDG 0.01%
RIET 0.01%
GYLD 0.01%It ranks #4 in the industry
Based on market cap of $530M.
XRN $530M PER 9.8
WELL $166B PER -
VTR $46B PER 159.3
DOC $15B PER 58.9
FAQ
What kind of company is XRN?
XRN belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of XRN?
The market cap of XRN is approximately $530M, ranking 3,178 within its sector.
Does XRN pay dividends?
XRN has a dividend yield of approximately 6.36%, with an annual dividend of $2.33.
What is the P/E ratio of XRN?
XRN has a P/E ratio of approximately 9.8x, which can be used to assess its valuation relative to the Real Estate sector average.
What is the 52-week high and low for XRN?
XRN has recorded a 52-week high of $39.93 and a low of $29.05.
